Today: 9 June 2026
Browse Category

EPA:ILD 21 June 2025 - 23 July 2025

Senegal’s Internet Revolution: How Fiber, 5G, and Policy Are Connecting a Nation

Senegal’s Internet Revolution: How Fiber, 5G, and Policy Are Connecting a Nation

Senegal had 11.3 million internet users in January 2025, covering 60.6% of the population, while mobile connections reached 22.7 million, or 121% penetration. Orange Sonatel launched 5G in Dakar on June 8, 2024, following Free’s 5G license in 2023. Fixed broadband subscriptions rose to 747,000 by end-2024, with fiber making up 57%. The 2Africa subsea cable landed in Dakar in late 2023.
23 July 2025
···
Internet Access in Vatican City: History, Infrastructure, Providers, and Modern Challenges

Internet Access in Vatican City: History, Infrastructure, Providers, and Modern Challenges

The Holy See launched its first website on December 25, 1995, and now manages its own ISP, .va domain, and fiber-optic network linking Vatican sites and properties. Vatican City relies on Italian mobile operators for 4G and 5G, with minimal public Wi-Fi. Satellite and fiber provide backup and broadcasting. Cybersecurity measures include a Vatican CERT set for 2025 and AI-driven defenses.
18 July 2025
·····
Internet Access in France: From Fiber to Satellite and Everything In Between

Internet Access in France: From Fiber to Satellite and Everything In Between

By end-2024, fiber reached 91% of premises in metropolitan France, passing over 40.6 million locations, with 75% of internet subscriptions now on fiber. About 5.8 million DSL lines remain as copper is phased out, with full retirement set for 2030. Over 45,000 5G sites are active, and Starlink has 60,000 French subscribers. The Cohésion Numérique program offers subsidies for satellite or wireless broadband in underserved areas.
21 June 2025
···

Stock Market Today

  • SailPoint Q1 Earnings Beat Estimates Amid Revenue Growth
    June 9, 2026, 10:14 AM EDT. SailPoint, Inc. (SAIL) reported Q1 earnings of $0.05 per share, surpassing the Zacks Consensus Estimate of $0.04 by 17.65%. Revenue increased to $280.14 million, beating estimates by 1.41% and up from $230.47 million a year ago. Despite earnings surprises and revenue growth, SailPoint shares have declined 12.6% year-to-date against the S&P 500's 8.2% rise. The company holds a Zacks Rank #3 (Hold), indicating expected market-aligned performance. Consensus estimates forecast Q2 EPS of $0.08 on $310.79 million revenue and fiscal year EPS of $0.32 on $1.27 billion revenue. Industry trends in the Zacks Internet-Software sector will influence future stock performance. Investors await management's commentary for guidance on sustainability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop